Plunkett Research Online: Eli Lilly and Company

ELI LILLY AND COMPANY (LLY:NYS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Eli Lilly and Company discovers, develops, manufactures and markets human pharmaceutical products. Human pharmaceutical products are grouped into five divisions: endocrinology, neuroscience, oncology, immunology and other. Endocrinology products include: Humalog, Humulin, Baqsimi, Basaglar, Trajen.....



Eli Lilly and Company
Ticker: LLY
Exchange: NYS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 317 276-2000
Fax:
Address: Lilly Corporate Center
Indianapolis, IN 46285 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceuticals Discovery & Development
ContactsDescription

Jeffrey SimmonsCEO, Subsidiary/President, Subsidiary
David RicksCEO/Chairman of the Board/Director/President
See More
Eli Lilly and Company discovers, develops, manufactures and markets human pharmaceutical products. Human pharmaceutical products are grouped into five divisions: endocrinology, neuroscience, oncology, immunology and other. Endocrinology products include: Humalog, Humulin, Baqsimi, Basaglar, Trajen.....See More See More

Auditor: EY
Legal Advisor: Covington & Burling LLP
$USD, In whole numbers,
except marked * or %
201920182017201620152014
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
Humalog
Trulicity
Forteo
Cymbalta
Zyprexa
Cialis
Loxo Oncology Inc
Dermira Inc
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: